KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Net Income (2016 - 2025)

Cme (CME) has disclosed Net Income for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Net Income rose 35.25% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.1 billion, a 15.5% increase, with the full-year FY2025 number at $4.1 billion, up 15.5% from a year prior.
  • Net Income was $1.2 billion for Q4 2025 at Cme, up from $908.0 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $1.2 billion in Q4 2025 to a low of $510.6 million in Q2 2021.
  • A 5-year average of $807.6 million and a median of $834.9 million in 2023 define the central range for Net Income.
  • Peak YoY movement for Net Income: skyrocketed 125.1% in 2021, then dropped 26.63% in 2022.
  • Cme's Net Income stood at $625.2 million in 2021, then grew by 2.03% to $637.9 million in 2022, then rose by 27.7% to $814.6 million in 2023, then increased by 7.37% to $874.6 million in 2024, then soared by 35.25% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Net Income are $1.2 billion (Q4 2025), $908.0 million (Q3 2025), and $1.0 billion (Q2 2025).